Fosamax Plus D

Active Ingredient(s): Alendronate Sodium + Cholecalciferol
FDA Approved: * April 7, 2005
Pharm Company: * MERCK
Category: Osteoporosis

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Fosamax Plus D Overview

Alendronic acid, sold under the brand name Fosamax among others, is a bisphosphonate medication used to treat osteoporosis and Paget's disease of bone.[1] It is taken by mouth.[1] Use is often recommended together with vitamin D, calcium supplementation, and lifestyle changes.[1] Common side effects include constipation, abdominal pain, nausea, and acid reflux.[1] Serious side effects may include esophageal problems, osteonecrosi...

Read more Fosamax Plus D Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Alendronic_acid

Recent Fosamax Plus D Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Fosamax Plus D: (3 results)

Sorted by National Drug Code

• 0006-0270 Fosamax Plus D 70/5600 (Alendronic Acid / Vitamin D3) Oral Tablet by Merck Sharp & Dohme Corp.
• 0006-0710 Fosamax Plus D 70/2800 (Alendronic Acid / Vitamin D3) Oral Tablet by Merck Sharp & Dohme Corp.
• 54868-5480 Fosamax Plus D 70/2800 (Alendronic Acid / Vitamin D3) Oral Tablet by Physicians Total Care, Inc.

Drugs with one or more similar ingredients: (3 results)

• ALENDRONATE SODIUM + CHOLECALCIFEROL 1 discussion
• ALENDRONATE + CHOLECALCIFEROL
• BINOSTO Alendronate Sodium1 discussion

Related Fosamax Plus D Topics: